RACHEL WELLS: Open Payments
NPI 1336444520 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 43 payments from 13 companies in 2025. Trend: 2023 $506 · 2024 $620 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $259 |
| Novo Nordisk Inc | 5 | $90 |
| Lilly USA, LLC | 4 | $82 |
| PFIZER INC. | 4 | $75 |
| Astellas Pharma US Inc | 3 | $66 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
Products named: UBRELVY, VRAYLAR, NURTEC ODT, Veozah, MOUNJARO, ZENPEP, Ozempic, Wegovy.
Industry payments across MO — which companies pay providers there.
